Effect of eprosartan on the hemostatic system in patients with chronic kidney disease associated with hereditary thrombophilia

Effect of eprosartan on the hemostatic system in patients with chronic kidney disease associated with hereditary thrombophilia

Aim. To study the effect of eprosartan, an angiotensin II type 1 (AT1) receptor blocker, with sympatholytic activity on the hemostatic system in patients with chronic kidney disease (CKD) associated with hereditary thrombophilia. Subjects and methods. The 12-week open-label uncontrolled trial includ...

Full description

Bibliographic Details
Main Authors: V V Kaliuzhin, O F Sibireva, O I Urazova, L M Tkalich, L I Zibnitskaia, E V Kaliuzhina, É A Sazonov, V Iu Grankina
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2013-09-01
Series:Терапевтический архив
Subjects:
chronic kidney disease
hereditary thrombophilia
eprosaptan
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31355

Internet

https://ter-arkhiv.ru/0040-3660/article/view/31355

Similar Items